Masatoshi Kudo, MD, PhD, Kindai University Faculty of Medicine
Advertisement
Articles by Masatoshi Kudo, MD, PhD, Kindai University Faculty of Medicine
Advertisement
Latest Updated Articles
Frontline I/O: Clinical Trial OverviewsPublished: June 29th 2020 | Updated:
R/R HCC: Second-Line OptionsPublished: June 29th 2020 | Updated:
REACH and REACH2 Trial OverviewPublished: June 29th 2020 | Updated:
I/O Second-Line TreatmentPublished: June 29th 2020 | Updated:
HCC Treatment Algorithm: Asia and EuropePublished: June 29th 2020 | Updated:
Frontline Therapy: Promising I/O CombinationsPublished: June 29th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
4
Meta-Analysis Characterizes Nivolumab/Ipilimumab Hyperprogression in Renal Medullary Carcinoma
5